Michigan approves ban on antidepressant tianeptine sodium

April 6, 2018

Michigan's governor has signed what's been described by state police as the nation's first statewide ban on the antidepressant tianeptine sodium.

The office of Republican Gov. Rick Snyder announced Thursday that he signed the measure to classify the as a Schedule II controlled substance, placing it in the same highly restrictive category that cocaine and fall under.

State police flagged the drug to a state lawmaker after a spate of gruesome overdoses in the Midland and Saginaw area in 2017.

Tianeptine sodium is an atypical antidepressant that is not approved by the Food and Drug Administration. It is marketed as a supplement or research chemical through unregulated vendors but is often abused in high doses to simulate opioid-like highs.

Explore further: FDA panel votes for tougher restrictions on hydrocodone

Related Stories

FDA panel votes for tougher restrictions on hydrocodone

January 26, 2013
(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor of moving hydrocodone ...

Strategies implemented to cut opioid ODs, deaths in maryland

June 15, 2017
(HealthDay)—Strategies are being implemented to reduce opioid overdoses and deaths in Maryland, according to a report published by the American Medical Association (AMA).

Opioid overdoses in ERs up 30 percent as crisis worsens

March 6, 2018
Emergency rooms saw a big jump in overdoses from opioids last year—the latest evidence the nation's drug crisis is getting worse.

New Mexico is 1st state to boost access to overdose antidote

April 6, 2017
New Mexico is the first state to require all local and state law enforcement agencies to provide officers with antidote kits as the state works to curb deaths from opioid and heroin overdoses.

Police try out new database for documenting opioid overdoses

August 14, 2017
Police in Massachusetts are testing a new database for documenting opioid overdoses they hope will help departments share information in real time and get people into treatment.

States ask insurers to prioritize non-opioid pain treatment

September 18, 2017
Attorneys general representing the majority of states are asking the insurance industry to encourage pain treatment through means other than prescriptions for opioid painkillers.

Recommended for you

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

August 7, 2018
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...

Unwise opioids for wisdom teeth: Study shows link to long-term use in teens and young adults

August 7, 2018
Getting wisdom teeth removed may be a rite of passage for many teens and young adults, but the opioid painkiller prescriptions that many of them receive could set them on a path to long-term opioid use, a new study finds.

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

August 1, 2018
A study led by Columbia University's Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly ...

US opioid use not declined, despite focus on abuse and awareness of risk

August 1, 2018
Use of prescription opioids in the United States has not substantially declined over the last decade, despite increased attention to opioid abuse and awareness of their risks, finds a study published by The BMJ today.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

oliverlu70
not rated yet Apr 07, 2018
How many is a "spate"? Tianeptine is not even sold in English-speaking countries as far as I'm aware.

Perhaps Big Pharma was threatened by the existence of an SSRE? (selective serotonin reuptake enhancer--works the opposite of SSRIs, makes you question their hypothesis about low serotonin levels causing depression).

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.